Myriad Genetics Inc (MYGN)

EBITDA

-$45.20M

TTM · Period ending: · USD

MYGN logo

MYGN EBITDA

Latest reported-$45.20M
MYGN TTM EBITDA (-$11.70M → -$45.20M)
High-resolution chart · PNG

MYGN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-9,407,941
-9,546,854
-9,491,136
-8,785,540
-8,243,393
-7,943,000
-7,637,885
-8,637,885
-9,437,885
-10,037,885
-10,800,000
-10,500,000
-9,800,000
-6,700,000
-7,300,000
-8,700,000
-10,000,000
-12,700,000
-11,700,000
-9,600,000
-5,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.